Biosafety of Mesoporous Silica Nanoparticles

Careful analysis of any new nanomedicine device or disposal should be undertaken to comprehensively characterize the new product before application, so that any unintended side effect is minimized. Because of the increasing number of nanotechnology-based drugs, we can anticipate that regulatory auth...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biomimetics (Basel)
Auteurs principaux: Rascol, Estelle, Pisani, Cédric, Dorandeu, Christophe, Nyalosaso, Jeff L., Charnay, Clarence, Daurat, Morgane, Da Silva, Afitz, Devoisselle, Jean-Marie, Gaillard, Jean-Charles, Armengaud, Jean, Prat, Odette, Maynadier, Marie, Gary-Bobo, Magali, Garcia, Marcel, Chopineau, Joël, Guari, Yannick
Format: Artigo
Langue:Inglês
Publié: MDPI 2018
Sujets:
Perspective
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352691/
https://ncbi.nlm.nih.gov/pubmed/31105244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomimetics3030022
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires